Global Blood Therapeutics

Quote
anonymous said:
Spoke to HR yesterday. They are really going through growing pains but will get there. Base is negotiable not sure of max. Let’s say it’s in the range of posters on here earlier. Bonus is quarterly with target of $44. The equity is what makes it attractive though. Not bad offer of shares which are RSUs BTW so more valuable than straight options at this point in time. ESOP also where you can participate and get best price when purchasing going back 24 months to best price. That’s huge if you can put some salary towards it. 4 weeks vacation. Closing bt Christmas and New Years normally but with possible launch? Not sure if it will be approved time off this year. 401k not too exciting. Match of up to $5 k I think, which is not much but again it’s the equity available. Auto allowance by a third party. Can’t tell you amount at this time bc it’s based on geography.

Start date will be October 1. Typical couple weeks home study and then home office.
Click to expand...

Thanks for the information. It sounds like a good job to gain speciality experience.

I am just concern about giving notice and purchasing a vehicle since my current Pharma job comes with a company car and the drug is delayed coming to the market or not approved. When the recruiter contacted me in June the position was with a September hiring date and training schedule and now it’s being pushed to October.

Does any one have a time frame of launch date?
 






anonymous said:
Oh boy!

Background checks online for 65 candidates before HR makes verbal offers?

This is going to take over 3 weeks for HR to call 65 sales candidates not including home office candidates they are hiring with verbal offers after online background checks.
Click to expand...

I agree, this company is already starting to turn me off. If you plan to expand the HR department should’ve already been fully staffed. I predict a takeover very soon, if one isn’t already in the works.
 






anonymous said:
Equity not great, only 800 shares, which at this point would be worth less than 40k. Cash signing bonuses with other companies can be higher than this. For a startup this is not a great equity offer.
Click to expand...
Yes but as stock rises so does the $40k. I knew gbt was going to be cheap but the stock has potential.
 






anonymous said:
Thanks for the information. It sounds like a good job to gain speciality experience.

I am just concern about giving notice and purchasing a vehicle since my current Pharma job comes with a company car and the drug is delayed coming to the market or not approved. When the recruiter contacted me in June the position was with a September hiring date and training schedule and now it’s being pushed to October.

Does any one have a time frame of launch date?
Click to expand...
What does this matter if you start Oct 1? You are being paid starting oct 1. IC is on MBO so almost guaranteed 11k that quarter.
 












anonymous said:
They also are hiring many home office positions if you look at their site. I think there is only one person in HR making offers and calls now so a lot of phone calls and leaving messages, tag you’re it type stuff going on also.
Click to expand...

So are they still making HR offer phone calls next week? Can’t possibly be done with so many candidates to call? Any real insights.
 










































I did read the study. 1 gram of hemoglobin increase?! Will that be enough for doctors to Rx? People that are interviewing are you leaving stable jobs for this gig? Really would like honest feedback. Worried abt the risk of leaving my current position with a stable company
 












Above poster, are you someone that looked at the opportunity and decided to not take it? I like the idea of rare disease and hematology space though. Wish I could get feedback from those who are taking the position on their reasons for accepting?
 






anonymous said:
Above poster, are you someone that looked at the opportunity and decided to not take it? I like the idea of rare disease and hematology space though. Wish I could get feedback from those who are taking the position on their reasons for accepting?
Click to expand...

Rare diseases is definitely a great specialty position to sell in but GBT voxelotor I would highly recommend to pass. I’ve been in the pharma industry for decades and would never recommend leaving a good gig to be with a new to market product with no clinical significance in its clinical trials. Furthermore the drug still isn’t approved and this is the only drug this company currently has in its pipeline. I have seen the fda take companies money for a fast track application/breakthrough therapy drug and still require more information to approve or the drug never come to market. If this drug was the next blockbuster big pharma would’ve brought the product and use their own sales force. Why do you think Novartis passed on buying the molecule.

This role is for reps who are new to the industry, running from a current situation with their job or unemployed and so desperate for a job because they can’t get hired by a real pharma company.
 






anonymous said:
Rare diseases is definitely a great specialty position to sell in but GBT voxelotor I would highly recommend to pass. I’ve been in the pharma industry for decades and would never recommend leaving a good gig to be with a new to market product with no clinical significance in its clinical trials. Furthermore the drug still isn’t approved and this is the only drug this company currently has in its pipeline. I have seen the fda take companies money for a fast track application/breakthrough therapy drug and still require more information to approve or the drug never come to market. If this drug was the next blockbuster big pharma would’ve brought the product and use their own sales force. Why do you think Novartis passed on buying the molecule.

This role is for reps who are new to the industry, running from a current situation with their job or unemployed and so desperate for a job because they can’t get hired by a real pharma company.
Click to expand...

Correction: Novo Nordisk not Novartis to acquire the SCD molecule.
 












anonymous said:
Rare diseases is definitely a great specialty position to sell in but GBT voxelotor I would highly recommend to pass. I’ve been in the pharma industry for decades and would never recommend leaving a good gig to be with a new to market product with no clinical significance in its clinical trials. Furthermore the drug still isn’t approved and this is the only drug this company currently has in its pipeline. I have seen the fda take companies money for a fast track application/breakthrough therapy drug and still require more information to approve or the drug never come to market. If this drug was the next blockbuster big pharma would’ve brought the product and use their own sales force. Why do you think Novartis passed on buying the molecule.

This role is for reps who are new to the industry, running from a current situation with their job or unemployed and so desperate for a job because they can’t get hired by a real pharma company.
Click to expand...
 












Top Bottom
Back
Quote